New federal lawsuit right targets gender clinics; named after activist, not victim.

What it does

This bill creates a federal civil lawsuit right against pediatric gender clinics, hospitals, universities, and doctors who provide gender-transition procedures (puberty blockers, hormone therapy, or surgery) to minors, allowing patients to sue for bodily injury or mental-health harm up to 30 years after turning 18. It also bars all federal funding to clinics, institutions, or procedures involved in pediatric gender transition.

Why we flagged it

The operative mechanism is twofold: (1) creation of a federal private right of action with punitive damages and a 30-year tail, and (2) a blanket federal funding prohibition. Both are designed to create legal and financial pressure on a specific medical practice category.

What the text implies

• The 30-year statute of limitations (from age 18 to age 48) creates perpetual liability exposure for clinics and practitioners, potentially chilling provision of the procedure even where state law permits it, because federal liability is independent of state authorization.
• The bill holds institutions (hospitals, universities) liable for 'affiliation' with a clinic—a vague standard that may expose large medical systems to liability for subsidiary or partner clinics they do not directly control, creating incentive to divest or distance themselves.
• The affirmative defense (clinic 'did not know and had no reason to know' the patient was a minor) is extremely narrow and places burden on defendant; a minor's misrepresentation of age may not be a complete defense if the clinic 'should have known.'
• Federal funding prohibition applies to any institution 'affiliated with' a pediatric gender clinic, potentially defunding entire hospital systems or universities if they maintain any connection to such a clinic, even in a research or educational capacity.
• The bill does not require proof of causation between the procedure and the claimed harm—only that harm is 'attributable, in whole or in part' to the procedure, a low evidentiary bar that may invite speculative or remote claims.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill creates a new private right of action and liability exposure for medical providers, potentially deterring or eliminating access to a category of medical care—a real constraint on treatment options for some families. However, it also establishes a legal remedy for patients who claim harm, and the underlying policy question (whether these procedures benefit or harm minors) is genuinely contested in medicine, law, and ethics, with no settled scientific consensus cited in the bill itself.

Who stands to gain

• plaintiff's personal injury bar (litigation windfall from new federal cause of action)
• medical malpractice insurers (increased claims and premiums)

Named in the bill

pediatric gender clinics, hospitals, institutions of higher education, medical practitioners, Pfizer (PFE), Bristol Myers Squibb (BMY), Gilead Sciences (GH), Johnson & Johnson (JNJ), DaVita (DVA), U.S. District Courts, State courts

Where it stands

2 cosponsors: 2 Republicans.

• Jan 29, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Jan 29, 2025 — Referred to Senate Committee on the Judiciary · Congress.gov: “Read twice and referred to the Committee on the Judiciary”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $439,908 in lobbying spend. A filing names 132 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Josh Hawley, the sponsor, reported $68,000 in PAC receipts in the 2026 cycle.

• Human Rights Campaign — $439,908 on 2 filings

Lobbying Disclosure Act filings through Jul 17, 2026. A filing shows who paid to lobby on a bill it names, not what changed.